期刊文献+

乳果糖联合美肠安胶囊对肝硬化伴自发性细菌性腹膜炎患者血浆降钙素原的影响

下载PDF
导出
摘要 目的探讨乳果糖联合关肠安(枯草杆菌.肠球菌二联活菌肠溶胶囊)对肝硬化伴自发性细菌性腹膜炎患者血浆降钙素原(PCT)水平的影响。方法选择肝硬化伴自发性细菌性腹膜炎患者76例,随机分为常规治疗组(36例)和联合治疗组(40例),另外选择单纯腹水30例为对照组。所有患者于治疗前、治疗第3天、第7天采用免疫色谱法检测血浆PCT水平。结果治疗前常规治疗组和联合治疗组患者血浆PCT水平显著高于单纯腹水组;联合治疗组PCT下降水平较常规治疗组显著(P〈0.01)。结论乳果糖联合双歧二联活菌可以有效抑制肠道致病菌的生长,减少内毒素的吸收,使血浆PCT水平显著下降。 bjective To investigate the change on plasma levels of procalcitonin among cirrhotic patients,to evaluate the thera- peutic effects of Lactulose and Probiotics in cirrhotic patients with spontaneous bacterial peritonitis(SBP).Methods the 106 cir- rhotic patients with ascites were elected into this study among whom there were 76 patients with SBP and 30 without SBP.76 pa- tients with SBP were randomized into two groups ,a treating group given Laetnlose and Probiotics.Plasma levels of PCT were mea- sured by a gold immunochromatographic assay and rapid semiquantitative PCT-Q test.plasm sample were collected at admission to the hospital and at the third day and the seventh day after admission.Result the positive rate of plasma PCT (〉 0.5 Ixg/L)were significantly higher in SBP group than those in without SBP group (P 〈 0.01 );there was no significant difference on the levels of plasma PCT in SBP group;after being treated for one week,the plasma levels of PCT were significantly decreased in Lactulose and probiotics treatment group than those in standard treatment group (P 〈 0.05).Conclusion the detection of plasma PCT has an important value in diagnosis and judgment of prognosis of SBP in liver cirrhosis.Oral Lactulose and probiotics is beneficial to hetmtitis cirrhotic patients with SBP.
出处 《中国药业》 CAS 2013年第A02期71-72,共2页 China Pharmaceuticals
关键词 乳果糖 益生菌 肝硬化 降钙素原 自发性细菌性腹膜炎 Lactulose probiotics cirrhosis Procalcitonin(PCT) spontaneous bacterial peritonitis(SBP)
  • 相关文献

参考文献3

二级参考文献15

  • 1蔺小红,席宏丽,斯崇文.肝硬化并发自发性细菌性腹膜炎患者腹水中TNF-α及IL-6的测定及其意义[J].中国实用内科杂志,2006,26(2):206-207. 被引量:16
  • 2张琳,石理兰,李洪军,赵桂珍.肝硬化和重型肝炎并发自发性细菌性腹膜炎128例临床特点分析[J].中国实用内科杂志,2006,26(2):224-225. 被引量:16
  • 3Asseray N,Leconte C,El Kouri D,et al.CRP in the management of bacterial infections in emergency.Presse Med,2005,34:561-565.
  • 4Aikawa N,Fujishima S,Endo S,et al.Multicenter prospective study of procalcitonin as an indicator of sepsis.J Infect Chemother,2005,11:152-159.
  • 5全国肝硬化专题学术讨论会;肝硬化腹水并发自发性细菌性腹膜炎的诊断参考标准[J].中华消化杂志,1989,9(6):359-359.
  • 6Choudhury J,Sanyal AJ.Treatment of ascites[J].Curr Treat Options Gastroenterol,2003,6 (6):481-491.
  • 7Filik L,Unal S.Clinical and laboratory features of spontaneous bacterial peritonitis[J].East Afr Med J,2004,81 (9):474-479.
  • 8Evans LT,Kim WR,Poterucha JT,et al.Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites[J].Hepatology,2003,37:897-901.
  • 9Franca A,Giordano HM,Seva-Pereira T,et al.Five days of ceftriaxone to treat spontaneous bacterial peritonitis in cirrhotic patients[J].J Gastroenterol,2002,37 (2):149-150.
  • 10Ginès P,Cárdenas A,Arroyo V,et al.Management of cirrhosis and ascites[J].N Eng J Med,2004,350:1646-1654.

共引文献14052

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部